Vanadyl sulfate as a senolytic: what the 2026 mouse study shows, and why the dose is the problem

Vanadyl sulfate is a vanadium salt sold online as a blood-sugar and bodybuilding supplement. On November 6, 2026, University of Chicago researchers reported in Nature Aging that it acts as a senolytic in mice: it selectively killed senescent ("zombie") cells, improved several signs of aging in old animals and extended median lifespan in male mice by about 7%. The story has spread quickly as a cheap, over-the-counter longevity supplement.

Short answer: this is a careful mouse study, not evidence that vanadyl sulfate slows aging in people. No human trial has looked at it as a senolytic. Human trials have looked at blood glucose and, in one trial, body composition in weight-training volunteers. The glucose studies are small, mostly from the 1990s and early 2000s, at doses many times the US safe upper limit for vanadium, with frequent stomach side effects. The authors themselves say its long-term safety needs full evaluation.

What the mouse study found

The team screened a library of nutrients and 68 added dietary supplements for compounds that kill senescent human cells while sparing normal ones, and vanadyl sulfate was a top hit. Old male mice, 76 weeks of age, given vanadyl sulfate in drinking water (0.15 mg per ml) for 13 weeks had better hanging endurance, less fat gain, better glucose tolerance and fewer markers of senescent cells than untreated old mice. Aged female mice showed similar improvements in endurance and metabolic measures. Young mice showed no benefit.

• Lifespan: male mice treated for three months from about 70 weeks of age had a median survival of 952 days, against 886.5 days for 20 untreated controls. There were 19 treated mice, one strain and one dose. Female lifespan was not measured.
• Disease models: vanadyl sulfate improved measures in mouse models of diabetes, fatty-liver fibrosis, chemically induced liver fibrosis, atherosclerosis and lung fibrosis.
• Durability: improvements in endurance, fat gain and glucose tolerance were largely kept after the supplement was stopped, while serum vanadium returned to baseline.
• Mechanism: senescent cells build up oxidized glutathione because glutathione reductase is reduced. Vanadyl sulfate does not itself raise oxidized glutathione; it oxidises reactive cysteines, causing protein misfolding and cell death, while normal cells cope.

Serum vanadium in the treated mice was about 300 micrograms per liter. The paper does not say what human dose would match that. In the discussion, the authors note that excessive vanadium exposure can impair lung function and eventually cause pulmonary fibrosis, and that a comprehensive evaluation of toxicity under long-term exposure is needed. The senior author is an inventor on a pending US patent application covering vanadyl sulfate for aging-related diseases and cancer, and another author holds equity in three biotech companies. The work was supported in part by the US National Institutes of Health, the Ludwig Center at the University of Chicago, the Harborview Foundation Gift Fund and the Howard Hughes Medical Institute.

What the human evidence shows

Vanadyl sulfate has been given to people, but never to slow aging or clear senescent cells. In 1996, 8 people with type 2 diabetes took 50 mg twice a day for four weeks; fasting glucose fell by about 20%, and six of the eight had stomach side effects in the first week. In a 2000 study of 16 patients over six weeks, insulin-stimulated glucose metabolism did not increase at 75 mg a day, while 150 mg and 300 mg lowered fasting glucose and HbA1c but caused some gastrointestinal intolerance; the authors concluded that at tolerated doses it does not dramatically improve insulin sensitivity or glucose control. A 2001 study gave 150 mg a day for six weeks to 11 patients and reported better glucose control. A 2008 systematic review found 151 studies, none of which met its inclusion criteria, and concluded there is no rigorous evidence that oral vanadium improves glucose control and that routine use cannot be recommended.

The bodybuilding claim has even less behind it. In a 12-week placebo-controlled trial in weight-training volunteers, vanadyl sulfate at 0.5 mg per kg of body weight a day made no difference to body composition; two people taking it withdrew because of apparent side effects.

The dose problem

In 2001 the US Institute of Medicine set a tolerable upper intake level for adults of 1.8 mg of elemental vanadium a day, based on kidney damage in rats. It could not set a safe limit for infants, children, teenagers, or pregnant or breastfeeding women. It said infants, children, and pregnant or breastfeeding women should be particularly cautious about vanadium supplements, and it said intake for teenagers should come from food. It also stated that there is no justification for adding vanadium to food and that vanadium supplements should be used with caution. Its calculations show how far typical doses go past that limit: 100 mg a day of vanadyl sulfate, the dose in early diabetes studies, provides about 31 mg of vanadium, roughly 17 times the upper limit. It reported that weight-training athletes use up to 60 mg a day of vanadyl sulfate, about 18.6 mg of vanadium. Median vanadium intake from supplements in US adults was about 9 micrograms a day.

Our view

• Do not take vanadyl sulfate for longevity on the strength of this study. It is a new finding, in mice, reported in one paper, and the lifespan result rests on 39 male mice.
• The doses used in the blood-sugar studies, and the doses weight-training athletes have been reported to take, are far above the US upper limit. Those trials were small and short, and the glucose trials often caused stomach side effects.
• The interesting part is the mechanism: the paper identifies a weakness specific to senescent cells that other compounds could also target. That is a reason for a properly designed human trial, not for self-experimenting.
• If you have diabetes, do not use vanadyl sulfate as a substitute for prescribed treatment; the 2008 review found no rigorous evidence that it controls blood glucose. Tell your doctor or pharmacist about any supplement you take.

US rules

Vanadyl sulfate can be sold in the US as a dietary supplement. FDA is not authorized to approve dietary supplements for safety and effectiveness before they are marketed. A product sold as a supplement but represented as treating or preventing a disease, such as diabetes, is regulated as a drug. Check the amount of elemental vanadium on any label against the 1.8 mg upper limit, and tell your doctor or pharmacist about any supplement you take, particularly if you take diabetes medicines.

FAQ

Is vanadyl sulfate a proven senolytic?

Only in cells and mice. The November 2026 Nature Aging paper reports the senolytic effect, and no human study has measured senescent cells or aging outcomes with it.

Did it extend lifespan?

In male mice, median survival rose from 886.5 to 952 days, about 7%, after three months of treatment starting in late middle age. Female lifespan was not measured.

Is vanadyl sulfate safe?

Short human studies at 100 to 300 mg a day reported mainly stomach cramps and loose stools, but they were small and lasted weeks, not years. The US upper limit for adults is 1.8 mg of vanadium a day, and no limit could be set for children or during pregnancy or breastfeeding.

What dose did the mice get?

0.15 mg per ml in drinking water, giving serum vanadium of about 300 micrograms per liter. The paper does not translate that into a human dose, and it should not be read as one.